Answers are grounded in this paper and cite their sources.
In patients with HBeAg-positive chronic hepatitis B, peginterferon alfa-2a offers superior efficacy over lamivudine, on the basis of HBeAg seroconversion, HBV DNA suppression, and HBsAg seroconversion.
No takes yet. Share an insight, caveat, or question.
Lau et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: